S. Schwarz et al., Studies on modified estrogens: Towards the synthesis of novel 14,15-cyclopropa[a]estra-1,3,5(10),8-tetraenes, PHARMAZIE, 56(11), 2001, pp. 843-849
To improve the ratio of non-hormonal to hormonal activity, estrogens 3 and
4 were modified at various molecule positions. Isomerization of the 14 alph
a ,15 zeta -methylene bridge, controlled 3-methoxy group cleavage with resp
ect to the 14 alpha ,15 alpha -methylene bridge stereochemistry, reduction
of the 8-double bond, and substitution of the oxyfunctionality at C-17 by a
methylene and a difluoromethylene moiety were in the focus. As a result of
in vivo and in vitro tests, compounds 27 and 29 were selected as potential
follow-up candidates of lead 3.